Market Tracker

08/22 11:02am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

45.30
BATS BZX Real-Time Price
As of 10:57am ET
 +1.35 / +3.07%
Today’s Change
17.25
Today|||52-Week Range
46.45
+79.41%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close43.95
Today’s open44.70
Day’s range44.65 - 45.90
Volume4,427
Average volume (3 months)612,573
Market cap$2.2B
Dividend yield--
Data as of 10:57am ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-40.62%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.87%
P/E ratio22.6
Price/Sales6.07
Price/Book11.45

Competitors

 Today’s
change
Today’s
% change
LOXOLoxo Oncology Inc+0.60+0.82%
SRPTSarepta Therapeutics...-0.05-0.14%
IRWDIronwood Pharmaceuti...+0.31+2.15%
HZNPHorizon Pharma PLC-0.04-0.30%
Data as of 11:02am ET, 08/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts